ICSI vs IVF: When the Injection Is Actually Justified

The honest picture, with numbers

ICSI — intracytoplasmic sperm injection — is not a different treatment from IVF. It is one step inside IVF done differently. Everything before it is identical: the same stimulation, the same monitoring, the same egg collection. The HFEA puts it plainly: your treatment will be exactly the same as with IVF, except that instead of mixing sperm with the eggs and leaving them to fertilise, an embryologist injects a single sperm into each egg.

The commercial question is whether you should pay for that difference. The regulator's answer, for people without a sperm problem, is no. The HFEA states there is currently no scientific evidence to support the use of ICSI for infertility not related to the male partner's sperm, that good practice guidelines from the British Fertility Society and recommendations from the European society do not recommend ICSI over standard IVF in those circumstances, and that opting for ICSI when it is not necessary may increase the cost of your treatment without clear evidence that it will improve your success.

The four rules in NG257

NICE guideline NG257, section 1.50, is short enough to hold in your head, and it is the most useful thing you can take into a consultation.

• 1.50.1 — Offer ICSI using surgically retrieved sperm or frozen-thawed oocytes. In these two situations it is the recommended route, not an optional extra.
• 1.50.2 — Consider ICSI if the partner with male reproductive organs has abnormal semen parameters, taking the severity into account, or if a previous IVF cycle resulted in failed fertilisation or a very low fertilisation rate.
• 1.50.3 — Do not use ICSI for non-male factor fertility problems if the semen parameters are normal.
• 1.50.4 and 1.50.5 — Do not use IMSI as an adjunct to ICSI, and do not use PICSI in preference to standard ICSI.

Notice the verbs. "Offer" is stronger than "consider", and "do not use" is not a preference. If ICSI is proposed to you, the useful question is simply which of 1.50.1 or 1.50.2 applies in your case.

Why there are no separate ICSI success rates

People often ask which has the better success rate. The HFEA does not publish separate statistics for ICSI, and explains why: ICSI is very successful at helping the sperm and egg to fertilise, but as in IVF there are many other factors affecting a successful pregnancy, including age and any fertility difficulties on the female side, so success rates for ICSI tend to be very similar to IVF.

That sentence contains the whole point. ICSI solves one specific problem — getting a sperm inside an egg. It does nothing about egg quality, embryo development, the endometrium or age. Which is also why the HFEA notes that if a previous cycle went badly because of poor quality or immature eggs, ICSI is unlikely to help.

The risks that are specific to ICSI

ICSI carries slightly more risk than conventional insemination, and the HFEA is specific about what that means:

• Eggs may be damaged when they are cleaned and injected.
• Certain genetic and developmental differences have been reported in a very small number of children born after ICSI, but problems linked with ICSI may have been caused by the underlying infertility rather than the technique.
• A boy conceived by ICSI may inherit his father's or the donor's infertility. The HFEA notes it is too early to be certain, as the oldest boys born from ICSI are still in their teens, but that where there is a clearly defined genetic cause of male infertility, particularly one associated with the Y chromosome, it is highly likely that male offspring will inherit it.

Where that last point may apply, the HFEA suggests considering genetic testing first and discussing the implications with the clinic's counsellor. NG257 separately tells clinicians to give people considering IVF, with or without ICSI, up-to-date information on long-term health outcomes, to say that while the absolute risks of long-term adverse outcomes are low a small increased risk of borderline ovarian tumours cannot be excluded, and to say that the absolute risks of long-term adverse outcomes in children born as a result of IVF are low.

The add-ons sold alongside it

Two sperm-selection techniques are routinely offered as upgrades to ICSI, and both are covered by NICE and by the HFEA's rated list. IMSI, intracytoplasmic morphologically selected sperm injection, uses higher magnification to choose the sperm; NG257 says do not use it as an adjunct to ICSI, and the HFEA rates it grey, meaning it cannot rate effectiveness because the evidence is insufficient. PICSI, physiological ICSI, selects sperm by their ability to bind hyaluronan; NG257 says do not use it in preference to standard ICSI, and the HFEA rates it black for patients having ICSI for male factor infertility, meaning the evidence shows no effect on the outcome.

Black is not "unproven". Black means it was studied and it did not work.

What to do next

1. Ask which NG257 recommendation justifies ICSI in your case — 1.50.1, 1.50.2, or neither.
2. Get the semen analysis result in front of you before agreeing. Recommendation 1.50.3 turns on whether the parameters are normal.
3. Ask what ICSI adds to the invoice, and whether it is bundled or itemised.
4. Decline IMSI and PICSI unless someone can tell you why NICE is wrong in your specific case.
5. If there is a known or suspected genetic cause of male infertility, ask about genetic testing and counselling before treatment rather than after.
6. If a previous cycle had failed or very low fertilisation, say so explicitly — that is one of the two triggers in 1.50.2.

When to seek help

NG257 recommends assessment of both partners after 1 year of unprotected vaginal intercourse, earlier referral at first presentation from age 36, and immediate referral where either partner has a known or suspected clinical cause of infertility. A male factor problem is exactly such a cause, and semen analysis is one of the first tests in the pathway — so if it has never been done, that is the gap to close before any conversation about injection techniques. The HFEA also notes that after unsuccessful ICSI many specialists advise waiting a couple of months before trying again, both to recover and to think.